Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Jun 27, 2026; 18(6): 117925
Published online Jun 27, 2026. doi: 10.4240/wjgs.117925
Published online Jun 27, 2026. doi: 10.4240/wjgs.117925
Table 3 Comparison of postoperative data, n (%)/median (interquartile rage)
| Routine care group (n = 146) | Comprehensive care group (n = 131) | P value | |
| Postoperative immunosuppressive induction | |||
| Basiliximab | 145 (99.32) | 128 (97.71) | 0.539 |
| Immunosuppressive maintenance | |||
| Cyclosporine A | 4 (2.74) | 4 (3.05) | 1.000 |
| Glucocorticoid | 124 (84.93) | 103 (78.63) | 0.173 |
| Tacrolimus FK506 | 139 (95.21) | 125 (95.42) | 0.993 |
| Mycophenolate mofetil | 37 (25.34) | 101 (77.10) | < 0.001 |
| Postoperative leukopenia | 30 (20.55) | 24 (18.32) | 0.640 |
| Postoperative mechanical ventilation time (hours) | 17 (12-60.5) | 16 (13-26.5) | 0.634 |
| ICU stay (days) | 7.9 (5.6-13.5) | 7.0 (4.8-11.5) | 0.481 |
| OAG score | |||
| Day 1 | 5 (5-6) | 5 (5-6) | 0.958 |
| Day 2 | 6 (5-7) | 6 (6-6) | 0.202 |
| Day 3 | 6 (6-7) | 6 (6-7) | 0.008 |
| Day 4 | 7 (7-8) | 7 (7-7) | 0.012 |
| Day 5 | 8 (8-9); n = 142 | 7 (7-7); n = 117 | < 0.001 |
| Day 6 | 9 (9-10); n = 121 | 7 (7-7); n = 98 | < 0.001 |
| Day 7 | 9 (9-10); n = 96 | 7 (7-7); n = 74 | < 0.001 |
| Day 8 | 9 (9-10); n = 83 | 7 (7-7); n = 66 | < 0.001 |
| Day 9 | 9 (9-10); n = 65 | 7 (7-7); n = 58 | < 0.001 |
| Day 10 | 9 (9-10); n = 53 | 7 (7-7); n = 50 | < 0.001 |
| Day 11 | 9 (9-10); n = 47 | 7 (7-7); n = 42 | < 0.001 |
| Day 12 | 9 (9-10); n = 40 | 7 (7-7); n = 35 | < 0.001 |
| Oral complications | 20 (13.70) | 7 (5.34) | 0.019 |
| Survival rate at ICU discharge | 98.63% | 99.23% | 1.000 |
- Citation: Zhang YY, Guo DX, Liu Y, Shang MY, Liu XY, Li JF. Comprehensive oral care protocol reduces oral complications in liver transplant recipients: A retrospective cohort study. World J Gastrointest Surg 2026; 18(6): 117925
- URL: https://www.wjgnet.com/1948-9366/full/v18/i6/117925.htm
- DOI: https://dx.doi.org/10.4240/wjgs.117925